These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35075977)

  • 21. A Small Contribution to a Large System: The Leptin Receptor Complex.
    Simien JM; Orellana GE; Phan HTN; Hu Y; Kurth EA; Ruf C; Kricek F; Wang Q; Smrcka AV; Haglund E
    J Phys Chem B; 2023 Mar; 127(11):2457-2465. PubMed ID: 36912891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor.
    Niv-Spector L; Raver N; Friedman-Einat M; Grosclaude J; Gussakovsky EE; Livnah O; Gertler A
    Biochem J; 2005 Sep; 390(Pt 2):475-84. PubMed ID: 15842201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations.
    Song LT; Tu J; Liu RR; Zhu M; Meng YJ; Zhai HL
    J Biomol Struct Dyn; 2019 Jul; 37(11):2970-2979. PubMed ID: 30058436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
    Paul M; Kumar Panda M; Thatoi H
    J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of leptin receptor N-linked glycans to leptin binding.
    Kamikubo Y; Dellas C; Loskutoff DJ; Quigley JP; Ruggeri ZM
    Biochem J; 2008 Mar; 410(3):595-604. PubMed ID: 17983356
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the binding mechanism of piperidinyl ureas inhibitors based on the UBC12-DCN1 interaction by 3D-QSAR, molecular docking and molecular dynamics simulations.
    Zhao J; Zang J; Yang J; Gao QB; Yan Y; Ma C; Chen Y; Ding L; Liu HM
    J Biomol Struct Dyn; 2022 Apr; 40(6):2674-2688. PubMed ID: 33183176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a soluble leptin receptor in crucian carp with different binding affinity to leptin-a and leptin-b.
    Xie F; Li X; Huang S; Li J; Guo X; Cao Y
    Comp Biochem Physiol B Biochem Mol Biol; 2016 Jan; 191():108-11. PubMed ID: 26478266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin: From structural insights to the design of antagonists.
    Zabeau L; Peelman F; Tavernier J
    Life Sci; 2015 Nov; 140():49-56. PubMed ID: 25998027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor.
    Kimber W; Peelman F; Prieur X; Wangensteen T; O'Rahilly S; Tavernier J; Farooqi IS
    Endocrinology; 2008 Dec; 149(12):6043-52. PubMed ID: 18703626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the suitability of RNA intervention mechanism exerted by some flavonoid molecules against dengue virus MTase RNA capping site: a molecular docking, molecular dynamics simulation, and binding free energy study.
    Manjula S; Kumaradhas P
    J Biomol Struct Dyn; 2020 Aug; 38(12):3533-3543. PubMed ID: 31514688
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the structure and conformational landscape of human leptin. A molecular dynamics approach.
    Chimal-Vega B; Paniagua-Castro N; Carrillo Vazquez J; Rosas-Trigueros JL; Zamorano-Carrillo A; Benítez-Cardoza CG
    J Theor Biol; 2015 Nov; 385():90-101. PubMed ID: 26342543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of activation mechanism and conformational stability of
    Sivanandam M; Manjula S; Kumaradhas P
    J Biomol Struct Dyn; 2019 Sep; 37(15):4006-4018. PubMed ID: 30301423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the binding properties of agonists interacting with glucocorticoid receptor: an in silico approach.
    Rathnayake S; Weerasinghe S
    J Mol Model; 2018 Nov; 24(12):342. PubMed ID: 30460461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin and leptin receptor genes in tongue sole (Cynoglossus semilaevis): Molecular cloning, tissue distribution and differential regulation of these genes by sex steroids.
    Xu Y; Zhang Y; Wang B; Liu X; Liu Q; Song X; Shi B; Ren K
    Comp Biochem Physiol A Mol Integr Physiol; 2018 Oct; 224():11-22. PubMed ID: 29852254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into the sequence-structure relationship of TLR cytoplasm's Toll/Interleukin-1 receptor domain towards understanding the conserved functionality of TLR 2 heterodimer in mammals.
    Ghosh SK; Saha B; Banerjee R
    J Biomol Struct Dyn; 2021 Sep; 39(15):5348-5357. PubMed ID: 32643540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular docking, 3D-QASR and molecular dynamics simulations of thiazoles Pin1 inhibitors.
    Zhao J; Liu M; Zang J; Yang S; Chen R; Zhao X; Ding L
    J Biomol Struct Dyn; 2022; 40(23):12699-12713. PubMed ID: 34499020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics.
    Wang RR; Liu WS; Zhou L; Ma Y; Wang RL
    J Biomol Struct Dyn; 2020 Mar; 38(5):1525-1538. PubMed ID: 31043123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.